Yoshiya Horimoto

49PUBLICATIONS
57CO-AUTHORS
Psychosocial aspects of childbirth and perinatal mental healthPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Japanese languageGenomics and transcriptomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Aug 14, 2026
Risk of febrile neutropenia in breast cancer chemotherapy despite the prophylactic use of pegfilgrastim: a retrospective analysis.

|Jul 17, 2026
IL-26-driven epigenetic remodeling promotes immune evasion in colorectal cancer.

|Jun 26, 2026
Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.

|May 18, 2026
Limits of substitution and context-dependent selective omission of Oncotype DX recurrence score testing.

|Mar 13, 2026
Clinical Outcomes and Prognostic Factors in Metastatic Triple-Negative Breast Cancer: A Real-World Data Analysis.

Moe Itakura, Yoshiya Horimoto, Yumiko Ushiyama

|Jan 31, 2026
Identifying immune-related predictive factors for post-eribulin therapy in patients with HER2-negative advanced breast cancer- a multicenter retrospective study.

Yuri Takamatsu, Yoshiya Horimoto, Yasuo Miyoshi

Pageof 9

Frequent Collaborators

12 joint publications

Takashi Ishikawa

9 joint publications

Junichiro Watanabe

6 joint publications

Hiroki Kusama

6 joint publications

Yumiko Ishizuka